Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Lander Willem

Showing results (51-60 of 73) with videos related to

Pageof 8
Sort By:
Scientific Reports|December 15, 2020
CoMix: comparing mixing patterns in the Belgian population during and after lockdownPietro Coletti, James Wambua, Amy Gimma, et al.
The Journal of Infection|September 15, 2014
Herpes zoster is associated with herpes simplex and other infections in under 60 year-oldsBenson Ogunjimi, Frank Buntinx, Stephaan Bartholomeeusen, et al.
Epidemics|April 2, 2021
Modelling the early phase of the Belgian COVID-19 epidemic using a stochastic compartmental model and studying its implied future trajectoriesSteven Abrams, James Wambua, Eva Santermans, et al.
Plos Computational Biology|August 22, 2022
Different forms of superspreading lead to different outcomes: Heterogeneity in infectiousness and contact behavior relevant for the case of SARS-CoV-2Elise J Kuylen, Andrea Torneri, Lander Willem, et al.
European Journal of Public Health|August 19, 2025
An extension of the Benefit Risk Assessment of VaccinEs toolkit to evaluate Comirnaty and Spikevax vaccination in the European UnionNeilshan Loedy, Hector G Dorta, Steven Abrams, et al.
The Lancet. Digital Health|April 9, 2025
Utilising the Benefit Risk Assessment of Vaccines (BRAVE) toolkit to evaluate the benefits and risks of Vaxzevria in the EU: a population-based studyHector Gonzalez Dorta, Johan Verbeeck, Jonas Crevecoeur, et al.
Nature Communications|March 22, 2021
The impact of contact tracing and household bubbles on deconfinement strategies for COVID-19Lander Willem, Steven Abrams, Pieter J K Libin, et al.
European Journal of Neurology|November 11, 2025
Recent Advances in Interventions Targeting Remyelination and a Systematic Review of Remyelinating Effects of Approved Disease-Modifying Treatments for Multiple SclerosisAnna-Victoria De Keersmaecker, Eline van Doninck, Inez Wens, et al.
Health Affairs (Project Hope)|December 4, 2023
Reflections On Epidemiological Modeling To Inform Policy During The COVID-19 Pandemic In Western Europe, 2020-23Mark Jit, Kylie Ainslie, Christian Althaus, et al.
BMC Public Health|April 26, 2024
The impact of quality-adjusted life years on evaluating COVID-19 mitigation strategies: lessons from age-specific vaccination roll-out and variants of concern in Belgium (2020-2022)Lander Willem, Steven Abrams, Nicolas Franco, et al.
Pageof 8

Showing results (51-60 of 73) with videos related to

Sort By:
Pageof 8
Scientific Reports|December 15, 2020
CoMix: comparing mixing patterns in the Belgian population during and after lockdownPietro Coletti, James Wambua, Amy Gimma, et al.
The Journal of Infection|September 15, 2014
Herpes zoster is associated with herpes simplex and other infections in under 60 year-oldsBenson Ogunjimi, Frank Buntinx, Stephaan Bartholomeeusen, et al.
Epidemics|April 2, 2021
Modelling the early phase of the Belgian COVID-19 epidemic using a stochastic compartmental model and studying its implied future trajectoriesSteven Abrams, James Wambua, Eva Santermans, et al.
Plos Computational Biology|August 22, 2022
Different forms of superspreading lead to different outcomes: Heterogeneity in infectiousness and contact behavior relevant for the case of SARS-CoV-2Elise J Kuylen, Andrea Torneri, Lander Willem, et al.
European Journal of Public Health|August 19, 2025
An extension of the Benefit Risk Assessment of VaccinEs toolkit to evaluate Comirnaty and Spikevax vaccination in the European UnionNeilshan Loedy, Hector G Dorta, Steven Abrams, et al.
The Lancet. Digital Health|April 9, 2025
Utilising the Benefit Risk Assessment of Vaccines (BRAVE) toolkit to evaluate the benefits and risks of Vaxzevria in the EU: a population-based studyHector Gonzalez Dorta, Johan Verbeeck, Jonas Crevecoeur, et al.
Nature Communications|March 22, 2021
The impact of contact tracing and household bubbles on deconfinement strategies for COVID-19Lander Willem, Steven Abrams, Pieter J K Libin, et al.
European Journal of Neurology|November 11, 2025
Recent Advances in Interventions Targeting Remyelination and a Systematic Review of Remyelinating Effects of Approved Disease-Modifying Treatments for Multiple SclerosisAnna-Victoria De Keersmaecker, Eline van Doninck, Inez Wens, et al.
Health Affairs (Project Hope)|December 4, 2023
Reflections On Epidemiological Modeling To Inform Policy During The COVID-19 Pandemic In Western Europe, 2020-23Mark Jit, Kylie Ainslie, Christian Althaus, et al.
BMC Public Health|April 26, 2024
The impact of quality-adjusted life years on evaluating COVID-19 mitigation strategies: lessons from age-specific vaccination roll-out and variants of concern in Belgium (2020-2022)Lander Willem, Steven Abrams, Nicolas Franco, et al.
Pageof 8